EUVIMEDEUVIMED entdecken
Crossref

TMEM97 knockdown inhibits 5‐fluorouracil resistance by regulating epithelial‐mesenchymal transition and ABC transporter expression via inactivating the Akt/ mTOR pathway in 5‐fluorouracil‐resistant colorectal cancer cells

Yi Xu, Yan Tang, Qiu Xu, Wenguang He

Chemical Biology & Drug Design · 2024-02 · 103 (2)

DOI: 10.1111/cbdd.14490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 22.02.2024. Verfasst von Yi Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Nanyang First People's Hospital, Nanyang, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Adenocarcinoma, Colorectal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Nanyang Basic and Frontier Research Project, Science and Technology Plan Project of Wolong District, Nanyang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to 5‐fluorouracil (5‐FU) is still a primary setback to the success of colorectal cancer (CRC) chemotherapy. Transmembrane protein 97 (TMEM97) functions as an oncogene in CRC. However, the role and mechanism of TMEM97 in regulating 5‐FU resistance in CRC cells remains unclear. TMEM97 expression in CRC samples was analyzed by GEPIA and human protein atlas (HPA) databases. TMEM97, E‐cadherin, Vimentin, N‐cadherin, P‐glycoprotein (P‐gp), multidrug resistance‐associated protein 1 (MRP1)/ABCC1, ABCC2, and the changes of protein kinase B/mammalian target of rapamycin (mTOR) pathway were explored by western blot analysis. IC50 value for 5‐FU and cell viability was examined by MTT assay. Apoptosis was evaluated by flow cytometry. TMEM97 was highly expressed in colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) based on GEPIA and HPA databases. TMEM97 knockdown attenuated 5‐FU resistance in HCT116/R and SW480/R cells, as evidenced by the reduced IC50 value for 5‐FU and the increased apoptosis. TMEM97 knockdown suppressed epithelial‐mesenchymal transition (EMT), expression of ATP‐binding cassette (ABC) transporters, and the Akt/mTOR pathway. Mechanistically, activation of Akt/mTOR pathway abolished the inhibitory effects of TMEM97 knockdown on 5‐FU resistance, EMT, and ABC transporter expression. In conclusion, TMEM97 knockdown inhibited 5‐FU resistance in CRC by regulating EMT and ABC transporter expression via inactivating the Akt/mTOR pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsAdenocarcinomaColorectal NeoplasmsHumansFluorouracilProto-Oncogene Proteins c-aktATP-Binding Cassette TransportersCell Line, TumorDrug Resistance, NeoplasmTOR Serine-Threonine KinasesEpithelial-Mesenchymal TransitionCell ProliferationGene Expression Regulation, NeoplasticMembrane Proteins

Stichwörter der Autor:innen

5-FU resistanceAkt/mTOR pathwayEMTTMEM97

Substanzen

FluorouracilProto-Oncogene Proteins c-aktATP-Binding Cassette TransportersTOR Serine-Threonine KinasesTMEM97 protein, humanMembrane Proteins

Autor:innen und Institutionen

  • Department of General Surgery, Nanyang First People's Hospital, Nanyang, China.
  • Department of Thyroid and Breast Surgery, Nanyang First People's Hospital, Nanyang, China.
  • Nanyang Key Laboratory of Thyroid Tumor Prevention and Treatment, Nanyang First People's Hospital, Nanyang, China.
  • Department of Thyroid and Breast Surgery, The Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Förderung

  • Nanyang Basic and Frontier Research Project
  • Science and Technology Plan Project of Wolong District, Nanyang

Zitieren

APA

Xu, Y., Tang, Y., Xu, Q., & He, W. (2024). TMEM97 knockdown inhibits 5‐fluorouracil resistance by regulating epithelial‐mesenchymal transition and ABC transporter expression via inactivating the Akt/ mTOR pathway in 5‐fluorouracil‐resistant colorectal cancer cells. Chemical Biology & Drug Design, 103(2). https://doi.org/10.1111/cbdd.14490

Vancouver

Xu Y, Tang Y, Xu Q, He W. TMEM97 knockdown inhibits 5‐fluorouracil resistance by regulating epithelial‐mesenchymal transition and ABC transporter expression via inactivating the Akt/ mTOR pathway in 5‐fluorouracil‐resistant colorectal cancer cells. Chemical Biology & Drug Design. 2024;103(2). doi:10.1111/cbdd.14490

BibTeX
@article{Xu2024,
  author = {Xu, Yi and Tang, Yan and Xu, Qiu and He, Wenguang},
  title = {TMEM97 knockdown inhibits 5‐fluorouracil resistance by regulating epithelial‐mesenchymal transition and ABC transporter expression via inactivating the Akt/ mTOR pathway in 5‐fluorouracil‐resistant colorectal cancer cells},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  volume = {103},
  number = {2},
  doi = {10.1111/cbdd.14490}
}
Kostenlos starten →